These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17249520)

  • 1. Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans.
    Okuro M; Morimoto S; Takahashi T; Okaishi K; Nakahashi T; Murai H; Iwai K; Kanda T; Matsumoto M
    Hypertens Res; 2006 Sep; 29(9):655-63. PubMed ID: 17249520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension.
    Iwatsubo H; Nagano M; Sakai T; Kumamoto K; Morita R; Higaki J; Ogihara T; Hata T
    Hypertension; 1997 Jan; 29(1 Pt 2):286-90. PubMed ID: 9039116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-acting ACE inhibitor (temocapril) and long-acting Ca channel blocker (amlodipine) on 24-h ambulatory BP in elderly hypertensive patients.
    Eguchi K; Kario K; Shimada K
    J Hum Hypertens; 2001 Sep; 15(9):643-8. PubMed ID: 11550111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients.
    Fogari R; Malamani GD; Zoppi A; Mugellini A; Rinaldi A; Vanasia A; Preti P
    J Hum Hypertens; 2003 Mar; 17(3):207-12. PubMed ID: 12624612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
    Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
    Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study.
    Higashi Y; Sasaki S; Nakagawa K; Ueda T; Yoshimizu A; Kurisu S; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2000 Feb; 35(2):284-91. PubMed ID: 10676671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
    Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
    Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study.
    Ohishi M; Takagi T; Ito N; Terai M; Tatara Y; Hayashi N; Shiota A; Katsuya T; Rakugi H; Ogihara T
    Hypertens Res; 2007 Sep; 30(9):797-806. PubMed ID: 18037772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
    Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
    Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients.
    Eguchi K; Kario K; Shimada K
    Hypertens Res; 2002 May; 25(3):329-33. PubMed ID: 12135309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.
    Higashi Y; Sasaki S; Nakagawa K; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2001 Mar; 37(3):863-70. PubMed ID: 11693763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of hypertension affects improved resistance artery endothelial function by angiotensin-converting enzyme inhibition.
    Higashi Y; Sasaki S; Nakagawa K; Kimura M; Sasaki S; Noma K; Hara K; Matsuura H; Goto C; Oshima T; Chayama K
    J Cardiovasc Pharmacol; 2002 May; 39(5):668-76. PubMed ID: 11973410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of AT1 inhibition and Ca2+-channel blockade in hypertensive patients during isometric stress.
    Arosio E; De Marchi S; Prior M; Rigoni A; Lechi A
    J Hum Hypertens; 2006 Mar; 20(3):201-5. PubMed ID: 16319906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension.
    Ueng KC; Lin LC; Voon WC; Lin MC; Liu YB; Su HM; Chang PY; Lin TH; Chen WL; Wu CC; Lai WT; Lin CS
    Blood Press Suppl; 2008 Jun; 1():24-31. PubMed ID: 18705532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
    Halimi JM; Giraudeau B; Buchler M; Al-Najjar A; Etienne I; Laouad I; Bruyère F; Lebranchu Y
    Clin Transplant; 2007; 21(2):277-84. PubMed ID: 17425758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.